Liquid Biopsy in Mature B-cell Tumors
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 444 (estimated)
- Sponsor
- Oncology Institute of Southern Switzerland · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThe study aims at assessing whether cell free DNA genotyping can improve the accuracy of early prediction of cure in mature B-cell tumor patients and whether it represents an accessible source of tumor DNA for the sensitive identification of genetic biomarkers that refine the diagnostic workup, stratify prognosis and identify the emergence of drug-resistance mutations during treatment.
Loading trial locations…